scholarly journals Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis

2008 ◽  
Vol 10 (5) ◽  
pp. 648-660 ◽  
Author(s):  
Judith M. de Bont ◽  
Johan M. Kros ◽  
Monique M.C.J. Passier ◽  
Roel E. Reddingius ◽  
Peter A.E. Sillevis Smitt ◽  
...  
2020 ◽  
Author(s):  
Chia-Feng Liu ◽  
Ying Ng ◽  
Varun Thachil ◽  
Michael Morley ◽  
Christine S Moravec ◽  
...  

Abstract Background: The Sry-related high-mobility-group box (SOX) gene family, with 20 known transcription factors in humans, plays essential roles during development and in many disease processes. Several SOX proteins, e.g., SOX4, SOX11, and SOX9, are required for normal heart morphogenesis. SOX9 was shown to contribute to cardiac fibrosis in animal models. However, differential expression of other SOX transcription factors and their functional roles in the failing human myocardium have not been explored.Methods and Findings: All 20 SOX genes from RNA-seq data were extracted, and their RNA levels were compared to the NF, DCM, and hypertrophic cardiomyopathy (HCM) groups. The protein levels of the differential expressed SOX genes were confirmed by Western blot. Four SOX genes whose RNA levels were significantly upregulated in DCM or HCM compared to NF. However, only SOX4 and SOX8 proteins were markedly increased in the heart failure groups. Gene co-expression network analysis identified genes associated and respond similarly to perturbations with SOX4 in cardiac tissues. Using a meta-analysis combining epigenetics and genome-wide association data, we reported several genomic variants associated with HF phenotype linked to SOX4 or SOX8.Conclusions: Elevation of SOX8 and SOX4 are observed in the failing human myocardium. The molecular mechanism associated with them in HF warrants further investigation.


Blood ◽  
2007 ◽  
Vol 110 (11) ◽  
pp. 2126-2126
Author(s):  
Claudia D. Baldus ◽  
Cornelia Schlee ◽  
Julia Thibaut ◽  
Sandra Heesch ◽  
Arend Bohne ◽  
...  

Abstract The oncogenic ETS transcription factor ERG is involved in various cellular pathways including developmental regulation, proliferation, and differentiation. In hematopoiesis ERG plays a specific role during normal T-cell differentiation showing high expression levels in stem cells and down regulation in the progenitor compartment. In this regard, it is intriguing that aberrant expression of ERG was found in a subset of patients with acute T-lymphoblastic leukemia (T-ALL) and was associated with an inferior outcome. Furthermore, high level ERG expression was of adverse prognostic significance in patients with newly diagnosed acute myeloid leukemia (AML), thus highlighting ERG’s potential role in myeloid as well as T-lineage leukemogenesis. ERG3 (NM_182918) and ERG2 (NM_004449) represent the main isoforms and show abundant expression in myeloid and lymphoid hematopoietic progenitor cells. The expression pattern of specific ERG isoforms in acute leukemias has yet to be investigated. To further elucidate the nature of aberrant ERG expression we have determined the existence and transcriptional regulation of ERG isoforms in pretreatment bone marrow samples of adult T-ALL (n=21) and AML (n=20) patients as well as in normal CD34+ hematopoietic cells of healthy volunteers (n=5). 5′RACE revealed the presence of a new ERG isoform (ERG3Δex12) characterized by expression of exon 5 and absence of exon 12. Expression of ERG3Δex12 was verified by RT-PCR in AML, T-ALL, and CD34+ cells. In addition, real-time RT-PCR showed concomitant expression of the two main isoforms ERG2 and ERG3 in AML and normal CD34+ cells. In contrast, T-ALL patients lacked expression of ERG isoforms harboring exon 4 (ERG2). Promoter analyses of ERG2 and ERG3 revealed the presence of two CpG islands in the ERG2 promoter region, whereas no CpG island was predicted in the ERG3 promoter. Bisulfit conversion of genomic DNA and sequencing of cloned PCR products revealed a significantly higher degree of methylation of CpG island 2 in T-ALL samples (median: 86.4%, range: 16.0 – 98.8%) as compared to AML (median: 38.1%, range: 10.9 – 60.7%; P-value=0.0002 - two sided T-test). As for CpG island 1, CD34+ cells had the lowest rate of methylation in CpG island 2 (median: 7.7%, range: 2.4 – 20.7%). Thus, the differential expression of ERG isoforms is mediated by epigenetic silencing of exon 4 containing transcripts in T-ALL. In conclusion, the identification of the new ERG isoform (ERG3Δex12) suggests the association with different partners as the central exons, including exon 12, guide the interaction with different proteins. Furthermore, the distinct expression of specific ERG transcripts controlled by methylation adds to the complexity of ERG directed downstream pathways in different leukemic subtypes.


2014 ◽  
Vol 26 (1) ◽  
pp. 152 ◽  
Author(s):  
V. Maillo ◽  
P. O'Gaora ◽  
J. P. Mehta ◽  
C. De Frutos ◽  
N. Forde ◽  
...  

Despite clear evidence of a two-way interaction between the developing conceptus and the uterine endometrium in early pregnancy, the evidence for reciprocal cross-talk during the transit of the embryo through the oviduct is less clear. The aims were (1) to characterise the transcriptome of the bovine oviduct at the initiation of embryonic genome activation (EGA), (2) to examine the effect, if any, of the presence of an embryo on the oviduct transcriptome, and (3) to compare gene expression in the ampulla and isthmus of the oviduct ipsilateral to the corpus luteum. The oestrous cycles of cross-bred beef heifers were synchronized and those recorded in standing oestrus were randomly allocated to control group, nonbred (n = 7), or AI group (n = 11). All heifers were slaughtered on Day 3 after oestrus. The oviducts from each animal were isolated, straightened, and cut in half (ampulla and isthmus). Each portion was flushed with 500 μL of PBS to confirm the presence of an oocyte/embryo and was then opened and scraped longitudinally to obtain epithelial cells. Cells were snap-frozen in liquid nitrogen for microarray analysis. All recovered oocytes and embryos were located in the isthmus of the oviduct ipsilateral to the corpus luteum. The recovery rate was 72.7% (8/11) and 83.3% (5/6) for pregnant and cyclic animals, respectively. The stage of the recovered embryos was as follows: 4-cell stage (n = 1), 8-cell stage (n = 5), and 8–16 cell stage (n = 2), whereas in the cyclic group all recovered structures were unfertilized oocytes. The cells of the isthmus from ipsilateral and contralateral oviducts from 5 cyclic and 5 pregnant animals (8-cell embryos) and the ipsilateral ampulla cells from the pregnant animals were used for microarray analysis (Affymetrix Bovine ST array, Affymetrix, Santa Clara, CA, USA). Array data were analysed using BioConductor packages in R and custom CDF files downloaded from MBNI. Preprocessing of raw data was performed with RMA, and differential expression was assessed by linear modelling implemented in the limma package. Genes displaying P < 0.05 after adjustment for multiple testing were considered differentially expressed. A total of 18 809 probe sets were assessed for differential expression. Comparison of pregnant and cyclic oviduct epithelium revealed no significantly altered genes. However, comparison of the isthmus and ampulla of the ipsilateral oviduct in pregnant animals revealed 4011 (P < 0.05) and 2327 (P < 0.01) differentially expressed genes. Some of the gene ontologies involved in biological processes included fatty acid metabolism, cell adhesion, cell morphogenesis, cellular developmental process, and reproduction. In conclusion, we have characterised the transcriptome of the bovine oviduct epithelium at the initiation of embryonic genome activation on Day 3 post-oestrus in pregnant and cyclic heifers. Although large differences in gene expression were observed between the isthmus and ampulla, data suggest that the presence of an 8-cell embryo had no effect on the transcriptome of the cells of the isthmus, although a local effect at the precise position of the embryo cannot be ruled out.


Blood ◽  
2005 ◽  
Vol 106 (11) ◽  
pp. 1448-1448
Author(s):  
Stuart S. Winter ◽  
Hadya Khawaja ◽  
Zeyu Jiang ◽  
Charles Kooperberg ◽  
Adolfo Ferrando ◽  
...  

Abstract Risk stratification remains limited for patients being treated for T-ALL due to a lack of biologic predictors of outcome. As a consequence, treatment assignment on modern protocols has been largely achieved through random assignment. Recent observations have suggested that overexpression of specific gene(s) may provide a reliable means to risk stratify patients. We hypothesized that microarray analysis may identify gene sets that distinguish both therapeutic response and patient outcome in T-ALL. We analyzed the gene expression profiles of 45 primary T-ALL samples (24 CCR, 21 relapse) from a matched, case control study with sufficient cRNA for microarray analysis (COG #8704). We performed oligonucleotide microarray analysis using Affymetrix U133Av.2 genechips which have approximately 54,000 target genes and ESTs. Following heirarchical clustering in dChip and R Language analyses (Chiaretti et al. Blood, 2004), but using RMA normalization, we identified 37 genes that serve as reliable predictors of CCR or relapse. Leave-one-out least discriminant analysis cross-over validation further constrained our prognostic gene identifiers to 21 genes of robust significance. These 21 genes predict 87 % of CCR and 82% of relapse accurately (p&lt;0.0001, two-tailed Fisher’s exact test). These results were verified by qRT-PCR. Transcriptional factors previously described as having prognostic significance were not identified in our study. Twenty-six of the 45 cases received high dose L-asparaginase (16 CCR, 10 relapse) on the companion study. As a result, we examined whether a distinct signature could be also identified that distinguishes response to dose-intensified asparaginase treatment for patients with T-ALL. Using the same approach, a 27-member gene signature was identified that accurately predicted response in 24 of the 26 cases (92 %; 2 cases of relapse were misclassified). These results have identified two sets of genes that may be further pursued as prognostic indicators in T-ALL or as predictors of response to therapy.


The Prostate ◽  
2003 ◽  
Vol 55 (1) ◽  
pp. 20-29 ◽  
Author(s):  
Tobias Zellweger ◽  
Christoph Ninck ◽  
Martina Mirlacher ◽  
Matthias Annefeld ◽  
Andrew G. Glass ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document